The authors also reported that low P4 levels and PR expression in CRC malignant tissues are linked with poor prognosis, suggesting that the hormone could inhibit cancer progression via a PR-mediated mechanism [96]. The gene discussed is PGR; the disease is colorectal carcinoma.